AVROBIO, Inc. (AVRO:NASDAQ) soared at $1.43, a gain of 46%. On Wed, Jul 12, 2023, AVRO:NASDAQ touched a New 2-Week High of $1.43. From Wed, Jun 28, 2023, the stock recorded 66.67% Up Days and 60.00% Green Days
The stock spiked on Mon, May 22, 2023 at $1.7 with a volume of 85M+.
About AVROBIO, Inc. (AVRO:NASDAQ)
Avrobio Inc is a clinical stage gene therapy company. It is engaged in the development of potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose.
Top 10 Gainers:
- Petros Pharmaceuticals Inc. (PTPI:NASDAQ), 93.37%
- The NFT Gaming Company Inc. (NFTG:NASDAQ), 90.07%
- Recursion Pharmaceuticals Inc. (RXRX:NASDAQ), 78.17%
- Ault Alliance Inc Com (AULT:NYSEMKT), 60.91%
- Freeline Therapeutics Holdings plc (FRLN:NASDAQ), 54.99%
- Camber Energy, Inc. (CEI:NYSEMKT), 48.91%
- InspireMD Inc. (NSPR:NASDAQ), 46.52%
- AVROBIO, Inc. (AVRO:NASDAQ), 45.96%
- Elys Game Technology Corp. (ELYS:NASDAQ), 43.7%
- Liminal BioSciences Inc. (LMNL:NASDAQ), 40%